Epilepsy Research Studies
Study Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sage-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus. (Identifier: NCT02477618)
Study Purpose: This is a randomized, double-blind, placebo-controlled trial, designed to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous infusion to subjects in Super-Refractory Status Epilepticus (SRSE).
Principal Investigator: Imran Ali, M.D.
Study Coordinator: Megan Murphy, for more information, please call 419-383-4516